• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vir Biotechnology Inc (NQ: VIR )

    9.370 -0.500 (-5.07%)
    Streaming Delayed Price Updated: 11:23 AM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Vir Biotechnology Inc

    < Previous 1 2
    ...
    6 7 8 9 10 11 12 13 Next >
    The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
    Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
    Via Benzinga
    World Markets News For Thursday
    Ericsson stock lost another 5.27% today in US markets. 
    Via Talk Markets
    Give peace a chance
    Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today. 
    Via Talk Markets
    Preprint Suggests, Vir-GSK's COVID-19 Antibody Can Evade Omicron Sub-Variant
    In January, amid the omicron surge, WHO's expert panel recommended GlaxoSmithKline Plc (NYSE 
    Via Benzinga
    Inflation inflating
    The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays. 
    Via Talk Markets
    Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus
    Immunome Inc (NASDAQ: IMNM) shares rose before falling after reporting results from testing its experimental three-antibody cocktail  
    Via Benzinga
    The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Panic reversal
    Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise. 
    Via Talk Markets
    WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
    An expert panel at the World Health Organization (WHO) recommended the use of treatments developed by Eli Lilly And Co (NYSE: LLY) and GlaxoSmithKline Plc... 
    Via Benzinga
    GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19
    GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have applied to the FDA to include intramuscular (IM) administration to sotrovimab... 
    Via Benzinga
    Vir Biotechnology Expands Partnership With Bill & Melinda Gates Foundation, Launches New Antibody Research Initiative Aimed At A Functional Cure For HIV And Prevention Of Malaria; Foundation Has Committed $40M Equity Investment And $10M Grant
    Vir Biotechnology, Inc. (NASDAQ: VIR) today announced an expansion of its partnership with the Bill & Melinda Gates Foundation to include the advancement of innovative... 
    Via Benzinga
    Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
    Adagio Therapeutics Inc (NASDAQ: ADGI) shares gain during the premarket session after recent findings showing that ADG20 has neutralization activity against the omicron... 
    Via Benzinga
    20 Stocks Moving in Thursday's Pre-Market Session
    Gainers BTCS Inc. (NASDAQ: BTCS) rose 41% to $9.45 in pre-market trading after jumping 19% on Wednesday. Adagio Therapeutics, Inc. (NASDAQ: ADGI) rose 22.8% to $7.16 in pre-... 
    Via Benzinga
    US To Purchase 600K Additional Doses of GSK-Vir's COVID-19 Antibody Therapy
    The U.S. has agreed to buy 600,000 more doses of GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 antibody... 
    Via Benzinga
    50 Biggest Movers From Yesterday
    Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for... 
    Via Benzinga
    Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
    Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The... 
    Via Benzinga
    The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus
    Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key... 
    Via Talk Markets
    The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
    Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating... 
    Via Benzinga
    Xmas Eve
    About 2000 flights which airlines were proposing to run today have been canceled because of virus not only amongst passengers but also among the crew. 
    Via Talk Markets
    Plague Year Reversal
    Just in time for Christmas, the market decided to go up today pretty much across the board. 
    Via Talk Markets
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 58.26% to $1.82 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 28.4... 
    Via Benzinga
    55 Biggest Movers From Yesterday
    Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) gained 44.8... 
    Via Benzinga
    38 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Reliance Global Group, Inc. (NASDAQ: RELI) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) climbed 71.4% to $13.06 after gaining... 
    Via Benzinga
    Alibaba Downgrade, Micron Upgrades Among Today's Top Calls On Wall Street
    Atlantic Equities analyst James Cordwell downgraded Alibaba to Neutral from Overweight with a price target of $140, down from $185. 
    Via Talk Markets
    Glaxo-Vir Biotech's Antibody Approved In Europe For Early Treatment Of COVID-19
    The European Commission (EC) has granted marketing authorization to GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR)... 
    Via Benzinga
    Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain
    Two tests from independent labs suggest Adagio's antibody could still target omicron. 
    Via Investor's Business Daily
    46 Biggest Movers From Yesterday
    Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Biofrontera (NASDAQ: 
    Via Benzinga
    Uncertain Times
    The UK inflation rate last month was 5.1%, not a good omen. 
    Via Talk Markets
    Mid-Day Market Update: REV Group Drops After Q4 Results; CMC Materials Shares Climb
    Midway through trading Wednesday, the Dow traded down 0.30% to 35,436.90 while the NASDAQ fell 0.57% to 15,150.48. The S&P also fell, dropping 0.23% to 4,623.57. The U.S. has... 
    Via Benzinga
    < Previous 1 2
    ...
    6 7 8 9 10 11 12 13 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.